AnalytiChem UK (formerly Cherwell) to demonstrate products aimed at ensuring reliability and reducing risk in microbial EM
Bicester, UK, 10th November 2025: AnalytiChem UK (formerly Cherwell), microbiology solutions expert, is to exhibit at Pharmig’s 33rd Annual Conference focusing on ‘Hot Topics in Pharmaceutical Microbiology’. To be held at Nottingham Belfry Hotel, 19-20th November, AnalytiChem UK will highlight its range of products for environmental monitoring (EM) and process validation in sterile medicinal product manufacturing.
Among the hot topics to be discussed at the conference, aimed at advancing microbiological best practice in pharmaceutical and related industries, will be a focus on contamination control strategies (CCS) and rapid microbiological methods (RMM). Both will also be spotlighted by AnalytiChem at the event, where it will demonstrate its new Redipor® TwistLock locking prepared media plates, BAMS real-time microbial monitor and Redipor® BetaBag – all are designed to ensure reliability and reduce risk in microbiological EM protocols, which are a key component of an effective CCS.
Recently launched, AnalytiChem’s new range of locking lid Redipor Twistlock plates ensure EM sample security throughout the microbial monitoring process to deliver reliable data and uphold product safety. Switching to locking plates instead of standard loose-lidded culture media plates offers a simple yet impactful way to maintain sample integrity, from point of collection to final reading, and support a robust CCS..jpg?width=350&height=233&name=Redipor%20Beta%20Bag%205%20(Resized).jpg)
AnalytiChem will also feature its Redipor® BetaBag, another easy and effective way to further reduce risk in EM. The BetaBag contains gamma-irradiated, ready-to-use microbiology media plates and supports EU GMP Annex 1 compliance by enabling validated, sterile transfer into Grade A environments. When connected to an Alpha port on an isolator or RABS, it provides a fully sealed, ‘no-touch’ transfer system, minimising operator contact and contamination risk. Gamma irradiation ensures sterility without additional decontamination steps, while the closed Alpha-Beta connection maintains containment integrity. These combined features provide validated, aseptic, and compliant material transfer, enhancing operator safety and contamination control.
The AnalytiChem UK team will be on hand to offer expert insight into developing reliable microbial EM programmes to support robust CCS. This expertise has been built from over 50 years’ experience and customer partnerships in the pharmaceutical and related industries. Microbiology Product Specialist, Yoggya De Silva and business development managers, Thomas Parkhill, Eleanor Corbett and Tom Pickford, will also be joined by colleagues from the global AnalytiChem Group.
“Reducing risk is fundamental to sterile pharmaceutical product manufacturing, and often small changes can deliver a big impact in achieving this. Through our high quality products, plus a flexible and reliable service with expert support, we help our customers to proactively manage risk,” said Yoggya De Silva, AnalytiChem UK. “Our long-standing heritage is built on forging strong partnerships and truly understanding our customers' needs, so we can provide the best guidance and support possible. Events like Pharmig give us a perfect opportunity to connect directly, deepen our industry insight, and stay current with the evolving needs of the pharmaceutical industry and our customers alike.”
Other specialist cleanroom microbiology products to be showcased on AnalytiChem UK’s stand at Pharmig’s annual conference include further products in its Redipor® prepared media range. Products contributing to sustainability initiatives, such as plastic bottled media and variably sized plated media packs, will be available. SAS microbial air samplers for active EM will also be on show alongside the BAMS real-time microbial monitors for continuous air monitoring.
